Notable are the EMPA-REG OUTCOME trial, which showed a significant reduction in aminotransferases with empagliflozin 47 , and a meta-analysis of ten randomized controlled trials with 573 participants that confirmed the superiority of SGLT2 inhibitors over other antihyperglycemic agents in terms of improvement in hepatic and metabolic parameters 48
1 The arrival of glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes, has reshaped the treatment landscape
See More Samantha holds a Bachelor of Arts in Communication Studies from Florida State University
Enebo LB, Berthelsen KK, Kankam M et al (2021) Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial